Journal Article (695)
2012
Journal Article
56 (4), pp. 1735 - 1743 (2012)
Antigen 85C Inhibition Restricts Mycobacterium tuberculosis Growth through Disruption of Cord Factor Biosynthesis. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Journal Article
80 (3), pp. 1274 - 1279 (2012)
Experimental Cerebral Malaria Develops Independently of Caspase Recruitment Domain-Containing Protein 9 Signaling. Infection and Immunity
Journal Article
80 (3), pp. 1274 - 1279 (2012)
Experimental Cerebral Malaria Develops Independently of Caspase Recruitment Domain-Containing Protein 9 Signaling. Infection and Immunity
Journal Article
5 (2), pp. 129 - 139 (2012)
Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease. Mucosal Immunology
Journal Article
92 (2), pp. 182 - 186 (2012)
Ability of Cricetomys rats to detect Mycobacterium tuberculosis and discriminate it from other microorganisms. Tuberculosis
Journal Article
92 (Suppl. 1), pp. S17 - S20 (2012)
Ten challenges for TB biomarkers. TUBERCULOSIS
Journal Article
8, pp. 290 - 299 (2012)
The volatiles of pathogenic and nonpathogenic mycobacteria and related bacteria. Beilstein Journal of Organic Chemistry
Journal Article
42 (2), pp. 374 - 384 (2012)
Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis. European Journal of Immunology
Journal Article
50 (2), pp. 274 - 280 (2012)
Diagnosis of Tuberculosis by Trained African Giant Pouched Rats and Confounding Impact of Pathogens and Microflora of the Respiratory Tract. Journal of Clinical Microbiology
Journal Article
15 (1), pp. 63 - 70 (2012)
Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis? CURRENT OPINION IN MICROBIOLOGY
Journal Article
12, 10 (2012)
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infectious Diseases
Journal Article
13 (1), pp. 71 - 82 (2012)
Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes and Immunity 2011
Journal Article
204 (10), pp. 1573 - 1584 (2011)
Recombinant BCG Delta ureC hly plus Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses. Journal of Infectious Diseases
Journal Article
29 (47), pp. 8740 - 8744 (2011)
Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens. Vaccine
Journal Article
17 (9), pp. 1323 - 1331 (2011)
Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients. Clinical Microbiology and Infection
Journal Article
11 (8), pp. 633 - 640 (2011)
Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infectious Diseases
Journal Article
6 (6), e20568 (2011)
The IFN-gamma-Inducible GTPase, Irga6, Protects Mice against Toxoplasma gondii but Not against Plasmodium berghei and Some Other Intracellular Pathogens. PLoS ONE
Journal Article
6 (6), e20568 (2011)
The IFN-gamma-Inducible GTPase, Irga6, Protects Mice against Toxoplasma gondii but Not against Plasmodium berghei and Some Other Intracellular Pathogens. PLoS ONE
Journal Article
11 (5), pp. 2152 - 2156 (2011)
Cells as Factories for Humanized Encapsulation. Nano Letters
Journal Article
41 (4), pp. 981 - 991 (2011)
Impact of inducible co-stimulatory molecule (ICOS) on T-cell responses and protection against Mycobacterium tuberculosis infection. European Journal of Immunology